強迫性障害(Obsessive-Compulsive Disorder)の治療薬パイプライン動向(2015年上半期版)...市場調査レポートについてご紹介

【英文タイトル】Obsessive-Compulsive Disorder - Pipeline Review, H1 2015

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Obsessive-Compulsive Disorder Overview 7
Therapeutics Development 8
Pipeline Products for Obsessive-Compulsive Disorder – Overview 8
Pipeline Products for Obsessive-Compulsive Disorder – Comparative Analysis 9
Obsessive-Compulsive Disorder – Therapeutics under Development by Companies 10
Obsessive-Compulsive Disorder – Therapeutics under Investigation by Universities/Institutes 11
Obsessive-Compulsive Disorder – Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Early Stage Products 14
Unknown Stage Products 15
Obsessive-Compulsive Disorder – Products under Development by Companies 16
Obsessive-Compulsive Disorder – Products under Investigation by Universities/Institutes 17
Obsessive-Compulsive Disorder – Companies Involved in Therapeutics Development 18
AbbVie Inc. 18
Addex Therapeutics Ltd 19
C4X Discovery Ltd 20
F. Hoffmann-La Roche Ltd. 21
Heptares Therapeutics Ltd. 22
Novartis AG 23
Omeros Corporation 24
Rottapharm SpA 25
Sellas Inc. 26
Obsessive-Compulsive Disorder – Therapeutics Assessment 27
Assessment by Monotherapy Products 27
Assessment by Target 28
Assessment by Mechanism of Action 30
Assessment by Route of Administration 32
Assessment by Molecule Type 33
Drug Profiles 34
ADX-71743 – Drug Profile 34
Product Description 34
Mechanism of Action 34
R&D Progress 34
ADX-88178 – Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
bitopertin – Drug Profile 36
Product Description 36
Mechanism of Action 36
R&D Progress 36
CR-5542 Series – Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
CR-5772 Series – Drug Profile 39
Product Description 39
Mechanism of Action 39
R&D Progress 39
dipraglurant IR – Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
fluvoxamine maleate – Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
mavoglurant – Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
methoxycoronaridine – Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
OMS-527 – Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Small Molecule to Antagonize Orexin 1 for Addiction and Compulsive Disorders – Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
Small Molecules to Antagonize Orexin-1 Receptor for CNS Disorders – Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
Small Molecules to Inhibit DAT and SERT for CNS Disorders – Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
zolpidem tartrate – Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Obsessive-Compulsive Disorder – Recent Pipeline Updates 51
Obsessive-Compulsive Disorder – Dormant Projects 57
Obsessive-Compulsive Disorder – Discontinued Products 58
Obsessive-Compulsive Disorder – Product Development Milestones 59
Featured News & Press Releases 59
Mar 19, 2013: Omeros Elucidates Mechanism Of PDE7 Inhibitors In Addiction 59
Appendix 60
Methodology 60
Coverage 60
Secondary Research 60
Primary Research 60
Expert Panel Validation 60
Contact Us 61
Disclaimer 61


【レポート販売概要】

■ タイトル:強迫性障害(Obsessive-Compulsive Disorder)の治療薬パイプライン動向(2015年上半期版)
■ 英文:Obsessive-Compulsive Disorder - Pipeline Review, H1 2015
■ 発行日:2015年1月22日
■ 調査会社:Global Markets Direct
■ 商品コード:GMDHC6064IDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。